TradingMarkets 7 Stocks You Need To Know For Today
Alkermes
(
ALKS |
Quote |
Chart |
News |
PowerRating)
and Cephalon
(
CEPH |
Quote |
Chart |
News |
PowerRating) said they
received an approvable letter from the FDA for Vivitrol, a once-a-month
injection to treat alcoholics.
ALKS’s
PowerRating is 6 and CEPH’s
PowerRating is 3.
Guidant
(
GDT |
Quote |
Chart |
News |
PowerRating)
told the FDA there were more problems with defibrillators.
GDT’s
PowerRating is 5.
Morgan Stanley raised its price target on
Merck
(
MRK |
Quote |
Chart |
News |
PowerRating) to $38. MRK’s
PowerRating is 6.
Morgan Stanley also raised its price target on
Celgene
(
CELG |
Quote |
Chart |
News |
PowerRating) to $71 from $65.
CELG’s
PowerRating is 5.
Morgan Stanley raised its price target on
Multi-Fineline
(
MFLX |
Quote |
Chart |
News |
PowerRating) to $50 from
$42.. MFLX’s
PowerRating is 7.
Bear Stearns raised its target on
Symbol Tech
(
SBL |
Quote |
Chart |
News |
PowerRating) to $16. SBL’s
PowerRating is 6.
How is your favorite stock PowerRated?Â
Click here.
Brice Wightman